☆ 4.5 Article

Clinical Disease Characteristics and Treatment Trajectories Associated with Mortality among COVID-19 Patients in Punjab, Pakistan

HEALTHCARE (2023)

Related references

Note: Only part of the references are listed.

Article Pharmacology & Pharmacy

Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain

Adriana Alvarez et al.

Summary: This study analyzed the prescription profile of COVID-19 infected inpatients in Aragon, Spain. The majority of patients received combination therapy with hydroxychloroquine, lopinavir/ritonavir, or azithromycin, along with other medications. However, there was insufficient evidence to recommend these treatments, and ongoing clinical trials are being conducted to determine the best treatment for SARS-CoV-2 infection.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2022)

Add to Collection

Article Infectious Diseases

Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis

Kentaro Shimizu et al.

Summary: This study aimed to evaluate the effects of ivermectin on gastrointestinal complications and ventilator-free days in COVID-19 patients. The results showed that ivermectin improved gastrointestinal complications and increased the number of ventilator-free days in severe COVID-19 patients undergoing mechanical ventilation.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2022)

Add to Collection

Article Virology

Do high-dose corticosteroids improve outcomes in hospitalized COVID-19 patients?

Gagan Kumar et al.

Summary: The study found that in COVID-19 patients, receiving corticosteroids equal to or greater than 40 mg MED was associated with higher in-hospital mortality.

JOURNAL OF MEDICAL VIROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

R. L. Gottlieb et al.

Summary: In symptomatic, nonhospitalized high-risk Covid-19 patients, a 3-day course of remdesivir significantly reduced the risk of hospitalization or death compared to placebo, with acceptable safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Pharmacology & Pharmacy

Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial

Negar Toroghi et al.

Summary: This study compared the efficacy and safety of different doses of dexamethasone in treating patients with moderate to severe COVID-19. The results showed that low-dose dexamethasone had better clinical response and longer survival compared to high-dose dexamethasone, with some adverse effects slightly higher in the intermediate and high-dose groups than in the low-dose group.

PHARMACOLOGICAL REPORTS (2022)

Add to Collection

Article Multidisciplinary Sciences

Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020

Nikolina Bogdanic et al.

Summary: The analysis of azithromycin consumption in Croatia from 2017 to 2020 showed an increasing trend, indicating potential overuse of azithromycin. During the COVID-19 epidemic, there was a significant increase in azithromycin distribution in both hospital and non-hospital pharmacies, likely influenced by the desire to offer and try available treatments even in the absence of strong scientific evidence.

PLOS ONE (2022)

Add to Collection

Article Pharmacology & Pharmacy

Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19

Raquel Moreno Diaz et al.

Summary: This observational study compared the 90-day mortality in two groups of patients with severe COVID-19 pneumonia who received tocilizumab within the first 10 days from symptom onset or after day 11. The results suggest that administering tocilizumab within the first 10 days may decrease mortality in COVID-19 patients.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY (2022)

Add to Collection

Article Endocrinology & Metabolism

Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry

Dante S. Harbuwono et al.

Summary: The study revealed that patients diagnosed with diabetes mellitus in Indonesia were more likely to develop more COVID-19 symptoms and had a higher risk of COVID-19 mortality. This finding highlights the importance of formulating COVID-19 prevention and management policies specifically for diabetes patients in Indonesia.

PRIMARY CARE DIABETES (2022)

Add to Collection

Article Hematology

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis

Adam Cuker et al.

Summary: These guidelines aim to support the use of anticoagulation for thromboprophylaxis in COVID-19 patients without confirmed or suspected VTE. One conditional recommendation is against the use of outpatient anticoagulant prophylaxis in discharged COVID-19 patients.

BLOOD ADVANCES (2022)

Add to Collection

Article Food Science & Technology

HEMATOLOGICAL AND SEROLOGICAL PARAMETERS FOR DETECTION OF COVID-19

Abduladheem Turki Jalil et al.

Summary: This study aims to confirm COVID-19 infection through hematological and C-reactive protein (CRP) tests. The results show significant differences in hematological markers between COVID-19 patients and the control group, with decreases in white blood cells, lymphocytes, platelets, monocytes, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean platelet volume, and plateletcrit. Additionally, CRP test results indicate that 85% of patients tested positive, suggesting its role in predicting the severity of COVID-19 infection.

JOURNAL OF MICROBIOLOGY BIOTECHNOLOGY AND FOOD SCIENCES (2022)

Add to Collection

Article Infectious Diseases

Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry

Jorge Calderon-Parra et al.

Summary: This study analyzed the outcomes of different immunosuppressive medications in COVID-19. The results showed that chronic corticosteroid therapy was associated with increased mortality, while other immunosuppressive drugs did not have an impact on mortality risk.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Add to Collection

Review Immunology

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis

Su-Yeon Yu et al.

Summary: This study found that IL-6 receptor antagonists, when used in combination with standard care treatment, can significantly reduce all-cause mortality and the risk of progression to invasive mechanical ventilation in COVID-19 patients. Particularly, tocilizumab treatment showed significant benefits in reducing mortality and mechanical ventilation risk in patients with moderate-to-severe COVID-19. The frequency of serious adverse events was lower in the tocilizumab treatment group compared to the standard of care treatment group.

EMERGING MICROBES & INFECTIONS (2022)

Add to Collection

Article Hematology

ISTH guidelines for antithrombotic treatment in COVID-19

Sam Schulman et al.

Summary: Antithrombotic agents, particularly heparins, are recommended for patients with COVID-19 to reduce thromboembolism risk. The optimal dosing and timing of these treatments, as well as the benefits of other antithrombotic agents, are still unclear. A panel of experts developed 12 recommendations based on high- to moderate-quality evidence, including the use of prophylactic or therapeutic dose heparin for different patient groups. Additional weak recommendations were made for the use of sulodexide, adding antiplatelet agents, and prophylactic rivaroxaban in select patients. Future updates will incorporate new evidence and may modify these recommendations.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Review Multidisciplinary Sciences

The potential molecular implications of adiponectin in the evolution of SARS-CoV-2: Inbuilt tendency

Hayder M. Al-Kuraishy et al.

Summary: Adiponectin, an adipokine, plays a critical role in regulating immune response and inflammation, and its reduction may contribute to the severity of viral infections, including COVID-19.

JOURNAL OF KING SAUD UNIVERSITY SCIENCE (2022)

Add to Collection

Article Critical Care Medicine

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 The Ivermectin in COVID Nineteen Study

Juliana Cepelowicz Rajter et al.

Summary: Ivermectin treatment was associated with lower mortality in COVID-19 patients, especially those with severe pulmonary involvement, suggesting its potential effectiveness in reducing mortality in hospitalized COVID-19 patients. Randomized controlled trials are needed to confirm these findings.

CHEST (2021)

Add to Collection

Review Critical Care Medicine

Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU A Systematic Review and Meta-analysis

Elinor Tan et al.

Summary: The systematic review and meta-analysis included 45 studies from 17 countries across four continents, involving 16,561 patients with severe COVID-19 admitted to ICUs. The study revealed that critically ill COVID-19 patients require substantial organ support, with a high mortality rate of 28.1% during hospitalization.

CHEST (2021)

Add to Collection

Article Infectious Diseases

Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study

Javier Martinez-Sanz et al.

Summary: This study found that among hospitalized COVID-19 patients, receiving tocilizumab treatment significantly reduced the risk of death and intensive care unit admission or death in patients with high C-reactive protein levels.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Hematology

Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis

Filip Ionescu et al.

Summary: The study found that higher doses of anticoagulants were associated with lower mortality in hospitalized COVID-19 patients. Both therapeutic and prophylactic doses of anticoagulants were shown to reduce the risk of death, but patients receiving therapeutic anticoagulants were more prone to major bleeding.

EUROPEAN JOURNAL OF HAEMATOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

An Overview of the Treatment Options Used for the Management of COVID-19 in Pakistan: Retrospective Observational Study

Hashaam Akhtar et al.

Summary: The study found that antibiotics were the most common choice for treating COVID-19 during the peak of the first wave in Pakistan, with Azithromycin being the most prescribed drug. This treatment approach may lead to antibiotic resistance and complications in immunocompromised patients with COVID-19.

JMIR PUBLIC HEALTH AND SURVEILLANCE (2021)

Add to Collection

Review Infectious Diseases

Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis

Bradley J. Langford et al.

Summary: The study estimated that approximately three-quarters of patients with COVID-19 receive antibiotic treatment, which is significantly higher than the estimated prevalence of bacterial co-infection. This suggests a potential for high rates of unnecessary antibiotic use in patients with COVID-19.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

C-reactive protein and clinical outcomes in patients with COVID-19

Nathaniel R. Smilowitz et al.

Summary: Elevated CRP levels at initial hospital presentation in COVID-19 patients are associated with an increased risk of venous thromboembolism, acute kidney injury, critical illness, and mortality. There is a dose-response relationship between CRP concentration and adverse outcomes, with patients with high levels of both CRP and D-dimer showing the greatest risk of adverse outcomes. Systemic inflammation, as measured by CRP, plays a significant role in predicting clinical outcomes in COVID-19.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Medicine, General & Internal

Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments

Marko Boban

Summary: The COVID-19 pandemic has caused millions of cases and hundreds of thousands of deaths globally, with a mortality rate of around 5%-7%. Currently, there is no vaccine or specific antiviral therapy, but various drugs are being tested in clinical settings for treatment. Advanced support systems like mechanical ventilation are used for severe cases, but only provide temporary relief without targeted antiviral therapy.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Add to Collection

Article Physiology

The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis

Bin Wang et al.

Summary: In COVID-19 patients, CKD/AKI were associated with worse outcomes compared with those without CKD/AKI. AKI was associated with higher risks of severity and mortality than CKD.

KIDNEY & BLOOD PRESSURE RESEARCH (2021)

Add to Collection

Letter Hematology

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era

Wei Qin et al.

THROMBOSIS RESEARCH (2021)

Add to Collection

Article Oncology

An analytical study of drug utilization, disease progression, and adverse events among 165 COVID-19 patients

Feng Sun et al.

Summary: The study on drug utilization, disease progression, and adverse drug events of 165 COVID-19 patients in Wuhan revealed that severe cases had a higher mortality rate, more glucocorticoid use, and less traditional Chinese medicine usage. Combination antiviral therapy may be beneficial for recovery, and attention should be paid to liver and kidney adverse events caused by medications.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Hypertension, a Moving Target in COVID-19 Current Views and Perspectives

Carmine Savoia et al.

Summary: COVID-19, caused by SARS-CoV-2, poses a high mortality rate and is currently a major global health concern. Male patients and older individuals, as well as those with chronic comorbidities, are at a higher risk of severe clinical manifestations. Experimental studies suggest that hypertension, particularly the activation of the renin-angiotensin system, may play a role in COVID-19 severity.

CIRCULATION RESEARCH (2021)

Add to Collection

Review Infectious Diseases

Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials

Chih-Cheng Lai et al.

Summary: The study found that remdesivir can improve the clinical outcomes of patients with COVID-19, with a 5-day regimen likely being sufficient. However, no mortality benefit was observed with remdesivir treatment, and there was no increased risk of adverse events.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Add to Collection

Article Virology

Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement

Jennie H. Best et al.

Summary: This study describes the baseline characteristics and treatment patterns of US patients hospitalized with a diagnosis of COVID-19 and pulmonary involvement. Differences were seen in medication use between different races, geographic regions, and months of hospitalization.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19

Luigi Di Filippo et al.

Summary: In this study, the Adpn/Lep ratio was found to be significantly different among COVID-19 patients of varying severity, and it was positively correlated with systemic inflammation, indicating a compensatory response mechanism. Patients with higher Adpn/Lep ratios were associated with better health conditions and lower mortality rates.

DIABETES & METABOLISM (2021)

Add to Collection

Article Medicine, General & Internal

Anticoagulation in COVID-19: reaction to the ACTION trial

Jeffrey S Berger et al.

LANCET (2021)

Add to Collection

Letter Medicine, General & Internal

Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic

Jonathan H. Watanabe et al.

JAMA NETWORK OPEN (2021)

Add to Collection

Article Medicine, General & Internal

Effect of High-Flow Oxygen Therapy vs Conventional Oxygen Therapy on Invasive Mechanical Ventilation and Clinical Recovery in Patients With Severe COVID-19 A Randomized Clinical Trial

Gustavo A. Ospina-Tascon et al.

Summary: In a randomized clinical trial conducted in Colombia, it was found that high-flow oxygen therapy through a nasal cannula significantly reduced the need for mechanical ventilation support and shortened time to clinical recovery in patients with severe COVID-19 compared to conventional oxygen therapy.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Review Respiratory System

Efficacy and Safety of Azithromycin for the Treatment of COVID-19: A Systematic Review and Meta-analysis

B. M. Ghea Mangkuliguna et al.

Summary: The study found that the use of azithromycin in COVID-19 patients did not result in superior clinical improvement, but it was well tolerated and safe to use.

TUBERCULOSIS AND RESPIRATORY DISEASES (2021)

Add to Collection

Article Physiology

Reduced adiponectin levels in patients with COVID-19 acute respiratory failure: A case-control study

Sean M. Kearns et al.

Summary: A retrospective case-control study found significantly lower levels of adiponectin in patients with COVID-19 respiratory failure compared to other infectious respiratory failure patients, even after adjusting for covariates. Larger studies are needed to confirm these findings and further investigate the relationship between adiponectin levels and COVID-19 respiratory failure.

PHYSIOLOGICAL REPORTS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

C-reactive protein and clinical outcomes in patients with COVID-19

Nathaniel R. Smilowitz et al.

Summary: Elevated CRP levels upon hospital admission in COVID-19 patients are associated with increased risks of VTE, AKI, critical illness, and mortality, suggesting a crucial role of systemic inflammation in the clinical course of COVID-19.

EUROPEAN HEART JOURNAL (2021)

Add to Collection

Article Hematology

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Ning Tang et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Hao Xu et al.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)

Add to Collection

Article Endocrinology & Metabolism

COVID-19 pandemic, coronaviruses, and diabetes mellitus

Ranganath Muniyappa et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)

Add to Collection

Article Hematology

COVID-19 and its implications for thrombosis and anticoagulation

Jean M. Connors et al.

BLOOD (2020)

Add to Collection

Letter Cardiac & Cardiovascular Systems

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

Liang Chen et al.

CARDIOVASCULAR RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study

Yan Deng et al.

CHINESE MEDICAL JOURNAL (2020)

Add to Collection

Article Infectious Diseases

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Adarsh Bhimraj et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Editorial Material Medicine, General & Internal

Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy Early Experience and Forecast During an Emergency Response

Giacomo Grasselli et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Add to Collection

Article Gastroenterology & Hepatology

COVID-19: Abnormal liver function tests

Qingxian Cai et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Environmental Sciences

The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway

Carlo Capalbo et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Add to Collection

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

Add to Collection

Article Infectious Diseases

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

Adam J. Kucharski et al.

LANCET INFECTIOUS DISEASES (2020)

Add to Collection

Review Gastroenterology & Hepatology

Liver injury in COVID-19: The current evidence

Saleh A. Alqahtani et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Add to Collection

Letter Infectious Diseases

Duration of SARS-CoV-2 viral shedding during COVID-19 infection

Guo-Qing Qian et al.

INFECTIOUS DISEASES (2020)

Add to Collection

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Gender Differences in Patients With COVID-19: Focus on Severity and Mortality

Jian-Min Jin et al.

FRONTIERS IN PUBLIC HEALTH (2020)

Add to Collection

Article Emergency Medicine

Novel Use of Home Pulse Oximetry Monitoring in COVID-19 Patients Discharged From the Emergency Department Identifies Need for Hospitalization

Sonia Shah et al.

ACADEMIC EMERGENCY MEDICINE (2020)

Add to Collection

Article Pharmacology & Pharmacy

Pharmaco-Immunomodulatory Therapy in COVID-19

John G. Rizk et al.

DRUGS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

Chao Gao et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Cell Biology

Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury

Jieyu Guo et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Add to Collection

Article Endocrinology & Metabolism

Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study

Jianfeng Wu et al.

BMJ OPEN DIABETES RESEARCH & CARE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

Masataka Nishiga et al.

NATURE REVIEWS CARDIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

New-Onset Diabetes in Covid-19

Francesco Rubino et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Hematology

Treatment for emerging viruses: Convalescent plasma and COVID-19

Bethany L. Brown et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

Add to Collection

Article Multidisciplinary Sciences

Chest CT findings related to mortality of patients with COVID-19: A retrospective case-series study

Yiqi Hu et al.

PLOS ONE (2020)

Add to Collection

Review Immunology

What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses

Nirupa Gadi et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Article Hematology

Anticoagulation and bleeding risk in patients with COVID-19

Nancy Musoke et al.

THROMBOSIS RESEARCH (2020)

Add to Collection

Article Infectious Diseases

Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach

Lorenzo Roberto Suardi et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Add to Collection

Review Infectious Diseases

COVID-19 outbreak: current scenario of Pakistan

A. Waris et al.

NEW MICROBES AND NEW INFECTIONS (2020)

Add to Collection

Article Endocrinology & Metabolism

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Bruce Bode et al.

JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Population Risk Factors for COVID-19 Mortality in 93 Countries

Muhammad Jawad Hashim et al.

JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2020)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Review of radiographic findings in COVID-19

Audrey E. Kaufman et al.

WORLD JOURNAL OF RADIOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

A model of disparities: risk factors associated with COVID-19 infection

Yelena Rozenfeld et al.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study

Chao Gao et al.

EUROPEAN HEART JOURNAL (2020)

Add to Collection

Article Multidisciplinary Sciences

The age-associated loss of ischemic preconditioning in the kidney is accompanied by mitochondrial dysfunction, increased protein acetylation and decreased autophagy

Stanislovas S. Jankauskas et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Medicine, General & Internal

A Multicenter Observational Study of Incretin-based Drugs and Heart Failure

Kristian B. Filion et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Review Endocrinology & Metabolism

Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review

Hector Eloy Tamez-Perez et al.

WORLD JOURNAL OF DIABETES (2015)

Add to Collection

Article Immunology

Influenza A Virus Exacerbates Staphylococcus aureus Pneumonia in Mice by Attenuating Antimicrobial Peptide Production

Keven M. Robinson et al.

JOURNAL OF INFECTIOUS DISEASES (2014)

Add to Collection

Article Immunology

Adiponectin Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Suppression of Endothelial Cell Activation

Jason M. Konter et al.

JOURNAL OF IMMUNOLOGY (2012)

Add to Collection

Article Endocrinology & Metabolism

Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes

Jin-Kui Yang et al.

ACTA DIABETOLOGICA (2010)

Add to Collection

Article Immunology

The immunopathogenesis of sepsis in elderly patients

SM Opal et al.

CLINICAL INFECTIOUS DISEASES (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.